The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients.

MLA

Vermorken, Bernd L., et al. “The VertiGO! Trial Protocol: A Prospective, Single-Center, Patient-Blinded Study to Evaluate Efficacy and Safety of Prolonged Daily Stimulation with a Multichannel Vestibulocochlear Implant Prototype in Bilateral Vestibulopathy Patients.” PloS One, vol. 19, no. 3, Mar. 2024, p. e0301032. EBSCOhost, https://doi.org/10.1371/journal.pone.0301032.

APA

Vermorken, B. L., Volpe, B., van Boxel, S. C. J., Stultiens, J. J. A., van Hoof, M., Marcellis, R., Loos, E., van Soest, A., McCrum, C., Meijer, K., Guinand, N., Pérez Fornos, A., van Rompaey, V., Devocht, E., & van de Berg, R. (2024). The VertiGO! Trial protocol: A prospective, single-center, patient-blinded study to evaluate efficacy and safety of prolonged daily stimulation with a multichannel vestibulocochlear implant prototype in bilateral vestibulopathy patients. PloS One, 19(3), e0301032. https://doi.org/10.1371/journal.pone.0301032

Chicago

Vermorken, Bernd L, Benjamin Volpe, Stan C J van Boxel, Joost J A Stultiens, Marc van Hoof, Rik Marcellis, Elke Loos, et al. 2024. “The VertiGO! Trial Protocol: A Prospective, Single-Center, Patient-Blinded Study to Evaluate Efficacy and Safety of Prolonged Daily Stimulation with a Multichannel Vestibulocochlear Implant Prototype in Bilateral Vestibulopathy Patients.” PloS One 19 (3): e0301032. doi:10.1371/journal.pone.0301032.